Compounding pharmacies form a vital link in the ecosystem of functional and integrative medicine. Yet their ability to provide patients with unique personalized medications and nutraceuticals is being threatened by regulatory overreach. Dr. John Kim, Pharm.D. is an expert on compounding and is director of Robinson Drug & Compounding Center. Why is BigPharma lobbying against bio-identical HRT? How might bias against compounding pharmacies limit innovative doctors’ options to personalize treatments; Why offering custom-tailored medications is preferable to a one-size-fits-all approach; Dr. Kim discusses natural hormones, low-dose naltrexone, innovative pain formulations, and novel intravenous products. Compounding pharmacies like his are essential providers of the unique medications and supplements that require specialized delivery systems for children with autism; How consumers can push back against restrictive regulations that threaten to deny them the benefits of compounded medications—The Alliance for Pharmacy Compounding is fighting for patients’ rights.